Gene Therapy Phone: 617-632-5064

From the first attempt at modifying human DNA in the early 1980s to the first clinical trials based on genetic engineering of the mid 1990s to the first commercialization of a genetically engineered cell product in 2002 gene therapy has moved from being a pioneering research field to becoming one of the most technologically advanced and promising clinical realities for the treatment of a wide spectrum of diseases and tumors.

Founded in 2010, our Gene Therapy Program has been at the forefront of the fight against rare genetic disorders affecting children. The success of our gene therapy clinical trials is due to our programs unique combination of basic research and clinical care and our ability to translate what we learn at the laboratory bench to the bedside care of the patients we treat.

Through our research capabilities and partnerships, we strive to excel in every step of the gene therapy process. Our research includes:

We work closely with industrial and translational academic partners, such as the Translab and Cell Manipulation cores at Dana-Farber Cancer Institute, to:

Learn more

Continue reading here:
Gene Therapy Research - Dana-Farber/Boston Children's ...

Comments are closed.